HKD 105.9
(-1.4%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -2.24 Billion USD | 24.74% |
2022 | -2.97 Billion USD | 19.09% |
2021 | -3.68 Billion USD | -348.91% |
2020 | -819.98 Million USD | -140.7% |
2019 | -340.66 Million USD | 33.79% |
2018 | -514.53 Million USD | -587.08% |
2017 | -74.88 Million USD | -6.63% |
2016 | -70.23 Million USD | -2507.61% |
2015 | 2.91 Million USD | 4961.67% |
2014 | -60 Thousand USD | -100.26% |
2013 | 23.43 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -1.5 Billion USD | 13.15% |
2024 Q1 | -1.73 Billion USD | 22.81% |
2023 Q4 | -2.24 Billion USD | 9.89% |
2023 Q1 | -2.99 Billion USD | -0.5% |
2023 Q3 | -2.48 Billion USD | 8.97% |
2023 FY | -2.24 Billion USD | 24.74% |
2023 Q2 | -2.73 Billion USD | 8.72% |
2022 Q4 | -2.97 Billion USD | 14.57% |
2022 Q3 | -3.48 Billion USD | 10.57% |
2022 FY | -2.97 Billion USD | 19.09% |
2022 Q2 | -3.89 Billion USD | -6.07% |
2022 Q1 | -3.67 Billion USD | 0.16% |
2021 Q3 | -683.77 Million USD | 37.62% |
2021 Q1 | -1.26 Billion USD | -54.05% |
2021 Q4 | -3.68 Billion USD | -438.34% |
2021 Q2 | -1.09 Billion USD | 13.23% |
2021 FY | -3.68 Billion USD | -348.91% |
2020 Q1 | -1.65 Billion USD | -387.0% |
2020 Q2 | -983.24 Million USD | 40.73% |
2020 Q4 | -819.98 Million USD | 32.83% |
2020 FY | -819.98 Million USD | -140.7% |
2020 Q3 | -1.22 Billion USD | -24.15% |
2019 Q4 | -340.66 Million USD | 40.33% |
2019 FY | -340.66 Million USD | 33.79% |
2019 Q2 | -643.56 Million USD | -30.3% |
2019 Q3 | -570.94 Million USD | 11.29% |
2019 Q1 | -493.9 Million USD | 4.01% |
2018 Q2 | -228.66 Million USD | 27.85% |
2018 FY | -514.53 Million USD | -587.08% |
2018 Q3 | -447.51 Million USD | -95.7% |
2018 Q4 | -514.53 Million USD | -14.98% |
2018 Q1 | -316.95 Million USD | -323.24% |
2017 FY | -74.88 Million USD | -6.63% |
2017 Q4 | -74.88 Million USD | -49.29% |
2017 Q3 | -50.16 Million USD | 53.67% |
2017 Q1 | -77.84 Million USD | -10.84% |
2017 Q2 | -108.27 Million USD | -39.09% |
2016 Q2 | -47.53 Million USD | 76.5% |
2016 Q4 | -70.23 Million USD | -4.04% |
2016 Q3 | -67.5 Million USD | -42.02% |
2016 Q1 | -202.29 Million USD | -7034.93% |
2016 FY | -70.23 Million USD | -2507.61% |
2015 Q1 | 44.39 Million USD | 74091.67% |
2015 Q3 | -6.82 Million USD | 38.59% |
2015 Q4 | 2.91 Million USD | 142.76% |
2015 FY | 2.91 Million USD | 4961.67% |
2015 Q2 | -11.1 Million USD | -125.02% |
2014 Q4 | -60 Thousand USD | 0.0% |
2014 FY | -60 Thousand USD | -100.26% |
2013 FY | 23.43 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | -76.36 Million HKD | -2835.242% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 142.561% |